These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21916240)

  • 1. [The use of silymarin in patients with toxic and viral liver diseases].
    Matveev AV; Koniaeva EI
    Eksp Klin Gastroenterol; 2011; (5):84-90. PubMed ID: 21916240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatoprotective properties of silymarin].
    Matveev AV; Koniaeva EI; Kurchenko VP; Shchekatikhina AS
    Eksp Klin Gastroenterol; 2011; (2):130-5. PubMed ID: 21560654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
    Pradhan SC; Girish C
    Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silymarin treatment of viral hepatitis: a systematic review.
    Mayer KE; Myers RP; Lee SS
    J Viral Hepat; 2005 Nov; 12(6):559-67. PubMed ID: 16255756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silymarin, a possible hepatoprotector in dairy cows: biochemical and histological observations.
    Tedesco D; Domeneghini C; Sciannimanico D; Tameni M; Steidler S; Galletti S
    J Vet Med A Physiol Pathol Clin Med; 2004 Mar; 51(2):85-9. PubMed ID: 15153078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of hepatic diseases in ambulatory medicine. Multicenter studies].
    Martines G; Mingrino GC; Cagnetta G; Copponi V
    Clin Ter; 1980 Jan; 92(1):33-58. PubMed ID: 7449307
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of silymarin nanoemulsion against carbon tetrachloride-induced hepatic damage.
    Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
    Arch Pharm Res; 2011 May; 34(5):767-74. PubMed ID: 21656362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatoprotective effect of thiophane in rats with experimental carbon tetrachloride-induced hepatitis].
    Smol'iakova VI; Plotnikov MB; Chernysheva GA; Ivanov IS; Prosenko AE; Kandalintseva NV
    Eksp Klin Farmakol; 2011; 74(8):37-40. PubMed ID: 22232913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury.
    Luangchosiri C; Thakkinstian A; Chitphuk S; Stitchantrakul W; Petraksa S; Sobhonslidsuk A
    BMC Complement Altern Med; 2015 Sep; 15():334. PubMed ID: 26400476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of Silybum marianum oil and legalon on lipid peroxidation and liver antioxidant systems in rats intoxicated with carbon tetrachloride].
    Batakov EA
    Eksp Klin Farmakol; 2001; 64(4):53-5. PubMed ID: 11589112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[The Pathogenetic Approaches to the Chronic Liver Diseases Treatment].].
    Golovanova EV
    Eksp Klin Gastroenterol; 2016; (5):65-73. PubMed ID: 28614647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of silymarin in the treatment of liver diseases.
    Saller R; Meier R; Brignoli R
    Drugs; 2001; 61(14):2035-63. PubMed ID: 11735632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year results of a randomised double-blinded trial evaluating silymarin for chronic hepatitis C.
    Strickland GT; Tanamly MD; Tadros F; Labeeb S; Makld H; Nessim D; Mikhail N; Magder LS; Afdhal NH; Medhat A; Abdel-Hamid M
    Dig Liver Dis; 2005 Jul; 37(7):542-3. PubMed ID: 15975544
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of silymarin on experimental liver lesions.
    Barbarino F; Neumann E; Deaciuc I; Ghelberg NW; Suciu A; Cotuţiu C; Racoviţă L; Stroilă C; Nagy S; Părău N; Toader S; Brilinschi C
    Med Interne; 1981; 19(4):347-57. PubMed ID: 7336095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary and secondary prevention of alcoholic liver cirrhosis].
    Beliakin SA; Pliusnin SV; Bobrov AN
    Voen Med Zh; 2013 Mar; 334(3):15-9. PubMed ID: 23808210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of ursodeoxycholic acid combined with silymarin in the treatment of chronic ethyl-toxic hepatopathy].
    Bettini R; Gorini M
    Clin Ter; 2002; 153(5):305-7. PubMed ID: 12510413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of lead toxicity on rat liver with Vitamin C and silymarin supplements.
    Shalan MG; Mostafa MS; Hassouna MM; El-Nabi SE; El-Refaie A
    Toxicology; 2005 Jan; 206(1):1-15. PubMed ID: 15590105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of silymarin and vitamin E on gentamicin-induced nephrotoxicity in dogs.
    Varzi HN; Esmailzadeh S; Morovvati H; Avizeh R; Shahriari A; Givi ME
    J Vet Pharmacol Ther; 2007 Oct; 30(5):477-81. PubMed ID: 17803742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milk thistle: Silybum marianum.
    Pepping J
    Am J Health Syst Pharm; 1999 Jun; 56(12):1195-7. PubMed ID: 10484652
    [No Abstract]   [Full Text] [Related]  

  • 20. Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B.
    Wei F; Liu SK; Liu XY; Li ZJ; Li B; Zhou YL; Zhang HY; Li YW
    Eur J Clin Microbiol Infect Dis; 2013 May; 32(5):657-69. PubMed ID: 23247631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.